Close Menu

NEW YORK (Genomeweb News) – Proteome Sciences this week lowered its full year 2014 guidance, citing delays in the timing of several contracts.

The company said that as a result it expects 2014 revenues to be "somewhat lower" than the £2.14 million ($3.35 million) in revenues it posted in 2013.

The company said that it expected the delayed revenues to be captured in 2015, based on strong growth in its biomarker services and TMT reagent businesses.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.